Chloroquine for the 2019 novel coronavirus SARS-CoV-2

Mullard, 2012, Drug repurposing programmes get lift off, Nat Rev Drug Discov, 11, 505, 10.1038/nrd3776

Zhou, 2020, A pneumonia outbreak associated with a new coronavirus of probable bat origin, Nature, 10.1038/s41586-020-2951-z

Savarino, 2006, New insights into the antiviral effects of chloroquine, Lancet Infect Dis, 6, 67, 10.1016/S1473-3099(06)70361-9

Rolain, 2007, Recycling of chloroquine and its hydroxyl analogue to face bacterial, fungal and viral infections in the 21st century, Int J Antimicrob Agents, 30, 297, 10.1016/j.ijantimicag.2007.05.015

Vincent, 2005, Chloroquine is a potent inhibitor of SARS coronavirus infection and spread, Virol J, 2, 69, 10.1186/1743-422X-2-69

Ksiazek, 2003, A novel coronavirus associated with severe acute respiratory syndrome, N Engl J Med, 348, 1953, 10.1056/NEJMoa030781

Balzarini, 2006, Inhibition of feline (FIPV) and human (SARS) coronavirus by semisynthetic derivatives of glycopeptide antibiotics, Antiviral Res, 72, 20, 10.1016/j.antiviral.2006.03.005

Keyaerts, 2004, In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine, Biochem Biophys Res Commun, 323, 264, 10.1016/j.bbrc.2004.08.085

Barnard, 2006, Evaluation of immunomodulators, interferons and known in vitro SARS-coV inhibitors for inhibition of SARS-coV replication in BALB/c mice, Antivir Chem Chemother, 17, 275, 10.1177/095632020601700505

de Wilde, 2014, Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture, Antimicrob Agents Chemother, 58, 4875, 10.1128/AAC.03011-14

Yu, 2014, Severe acute respiratory syndrome beyond Amoy Gardens: completing the incomplete legacy, Clin Infect Dis, 58, 683, 10.1093/cid/cit797

Wang, 2020, Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro, Cell Res

Agostini, 2018, Coronavirus susceptibility to the antiviral remdesivir (GS-5734) is mediated by the viral polymerase and the proofreading exoribonuclease, mBio, 9, 10.1128/mBio.00221-18

White, 2014, Malaria, Lancet, 383, 723, 10.1016/S0140-6736(13)60024-0

Al-Bari, 2015, Chloroquine analogues in drug discovery: new directions of uses, mechanisms of actions and toxic manifestations from malaria to multifarious diseases, J Antimicrob Chemother, 70, 1608, 10.1093/jac/dkv018

Lee, 2011, The role of antimalarial agents in the treatment of SLE and lupus nephritis, Nat Rev Nephrol, 7, 718, 10.1038/nrneph.2011.150